Name: UMIN ID:
Unique ID issued by UMIN | UMIN000029601 |
---|---|
Receipt number | R000033815 |
Scientific Title | Safety and efficacy of pembrolizumab as first-line treatment in non-small cell lung cancer patients with poor performance status: a pilot study. |
Date of disclosure of the study information | 2017/10/18 |
Last modified on | 2019/05/05 12:44:27 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2017/10/17 22:27:27 | ||
2 | Update | 2017/10/19 14:15:45 | Public title Acronym |
|
3 | Update | 2017/10/19 14:19:46 | Organization1 Tel1 Email1 |
|
4 | Update | 2018/05/30 13:13:00 | Acronym |
|
5 | Update | 2018/05/30 13:15:45 | Public title |
|
6 | Update | 2019/05/05 12:44:27 | Recruitment status Date of IRB Last follow-up date |